The big winners of the tech wreck are biopharma stocks

BP targets $33B-$35B financial obligations by end of 2026 as it prioritizes Deepwater Horizon paydown

OmniAb outlines $35M-$39M 2026 revenue outlook, backed by Eli Lilly deal and xPloration doubling plan

Newell brands forecasts 2026 net sales growth of 2% to 3% while keeping normalized EPS midpoint at $0.75

Standard motor products outlines 11%-12% 2026 adjusted EBITDA margin while targeting further warehouse ramp in 2027